You are here
FDA's MedWatch Updates
Methylin CT (Methylphenidate HCl Chewable Tablets) - Recall of one lot due to health risk associated with excess active ingredient in product.
Aranesp (darbepoetin alfa) - WARNINGS and PRECAUTIONS sections revised to include reports of increased mortality and thrombotic vascular events.
Source: MedWatch, the FDA Safety Information and Adverse Event Reporting Program